Mechanism of Action

Components of Mechanism of Action

Molecular Target

What the drug directly interacts with:

• Receptors (most peptides)
• Enzymes
• Ion channels
• Transporters

Binding Interaction

How the drug interacts with its target:

• Agonist (activates)
• Antagonist (blocks)
• Modulator (adjusts activity)
• Inhibitor (reduces enzyme function)

Downstream Effects

What happens after target engagement:

• Signal transduction
• Gene expression changes
• Physiological responses

Mechanism Examples: Peptide Drugs

Semaglutide (GLP-1 Agonist)

Semaglutide
    ↓ binds to
GLP-1 Receptor (pancreas, brain, gut)
    ↓ activates
Multiple Pathways:
• Pancreas: Enhanced insulin secretion
• Pancreas: Reduced glucagon
• Brain: Reduced appetite
• Stomach: Slowed emptying
    ↓ results in
Lower blood sugar + weight loss

Tirzepatide (Dual Agonist)

Tirzepatide
    ↓ binds to
GLP-1 Receptor + GIP Receptor
    ↓ activates
Enhanced Incretin Signaling:
• GLP-1 pathway effects
• Plus GIP pathway effects
    ↓ results in
Greater glucose control + weight loss

Ipamorelin (GH Secretagogue)

Ipamorelin
    ↓ binds to
Ghrelin Receptor (GHS-R) in pituitary
    ↓ triggers
Growth hormone release
    ↓ leads to
IGF-1 production, metabolic effects

Why Mechanism Matters

Reason	Explanation
Predicting effects	Know what the drug should do
Understanding side effects	Know what else it might affect
Drug interactions	Identify pathway overlaps
Patient selection	Match mechanism to disease
Combination therapy	Use complementary mechanisms

Well-Characterized vs Poorly Characterized MOA

Well-Characterized

• GLP-1 agonists: Clear receptor target, validated pathway
• Growth hormone: Established pituitary mechanisms

Less Characterized

• BPC-157: Multiple proposed mechanisms, not fully established
• Some research peptides: Effects observed but pathways unclear

MOA in Drug Development

Target Identification
        ↓
Mechanism Hypothesis
        ↓
In Vitro Validation
        ↓
In Vivo Confirmation
        ↓
Human Studies
        ↓
Mechanism Refinement

Reading MOA Information

When evaluating peptide claims:

Claim Level	Confidence
”Binds to X receptor”	Direct evidence from binding studies
”Activates X pathway”	Functional studies showing activation
”May work through…”	Hypothesis, less certain
”Mechanism unknown”	Effects observed but MOA unclear

Frequently Asked Questions

Why do some drugs have multiple mechanisms?

Many drugs affect more than one target. Tirzepatide hits two receptors (GLP-1 and GIP). Sometimes multiple mechanisms are intentional (enhanced effect); sometimes they explain side effects (off-target activity).

Can the same mechanism produce different effects?

Yes. The same receptor exists in different tissues and can produce different effects when activated. GLP-1 receptors in pancreas affect insulin; in brain affect appetite; in stomach affect emptying speed.

Does knowing MOA guarantee the drug works?

No. A drug might bind its target perfectly but still fail clinically due to poor pharmacokinetics, compensatory mechanisms, or differences between model systems and human disease. MOA is necessary but not sufficient for success.